CT053PTSA aracterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients wit https://t.co/pTWJCJGZRd https://t.co/xB1ziZ85wQ
78 followers
73 followers
Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors https://t.co/jR6q2wek32
1,384 followers
Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors by Yu-Xiang Ma https://t.co/MwehoNLzvX
73 followers
Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors https://t.co/l9PtZT1x58